MedTrace Logo

Evaluation of miRNAs in Endometriosis

NCT04728152 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-01-28

No results posted yet for this study

Summary

We therefore propose a research project based on the prospective evaluation of miRNAs (blood and salivary) in patients with endometriosis diagnosed (by clinical examination and imaging) or suspected of endometriosis (clinical/radiological discordance) and in need of management in routine care (surgical or medical PMA) in the Endometriosis Expert Center Hospital.

Conditions

  • Endometriosis
  • Endometriosis Fertility
  • Endometriosis-related Pain

Interventions

OTHER

Blood and salivar test

Saliva samples will be taken (concomitant with a visit carried out as part of routine care): * At the pre-therapy visit (t3), * At the post-treatment visit (at 3-6 weeks). Blood samples will be taken at two stages (concomitant with a blood test performed as part of routine care): * At the pre-therapy visit (t3), * At the post-treatment visit (at 3-6 weeks).

Sponsors & Collaborators

  • Groupe expert en endometriose-6 centre expert en endometriose

    lead OTHER

Principal Investigators

  • EMILE DARAI, PROF · Centre Expert En Endométriose (C3E)

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2021-12-31
Completion
2022-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04728152 on ClinicalTrials.gov